The concentration at which Pf-2545920 increases intracellular cGMP and cAMP levels not only parallel the concentration range required to activate PKG and PKA, but also parallels the IC50 value to inhibit colon tumor cell growth as shown in Figure 1A. This evidence concerns the gene PRKG1 and colonic neoplasm.